Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience

201926 citationsJournal Articlegold Open Access

Authors

Abu‐Sayeef Mirza · University of South Florida

Seongseok Yun · Moffitt Cancer Center

Najla Al Ali · Moffitt Cancer Center

Hannah Shin · University of South Florida

Joseph Luke O’Neil · University of South Florida

Maher Elharake · Moffitt Cancer Center

Daniel P. Schwartz ·

Abstract

Although there was an increased risk of thrombosis associated with a higher KRS among AML patients with a KRS of 1 to 3, the difference was not statistically significant. Furthermore, only a few patients were found to have a KRS > 3, and this was largely due to pancytopenia, which is commonly associated with AML. These results indicate the need for a better thrombotic risk-scoring system for AML patients.

Topics & Keywords

Venous Thromboembolism Diagnosis and Management Hematological disorders and diagnostics Myeloproliferative Neoplasms: Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Thrombosis Journal

Volume 17, Issue 1, pp. 13-13

DOI: 10.1186/s12959-019-0202-z

Field-Weighted Citation Impact: 2.87